Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.75 |
| ▸ | CES1 | P23141 | 4/20 | 0.75 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.68 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.64 |
| ▸ | PPARG | P37231 | 7/20 | 0.64 |
| ▸ | PPARD | Q03181 | 7/20 | 0.64 |
| ▸ | PPARA | Q07869 | 7/20 | 0.64 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.64 |
| ▸ | TSHR | P16473 | 4/20 | 0.64 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | TLR2 | O60603 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | FABP4 | P15090 | 2/20 | 0.64 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.64 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | ESR1 | P03372 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL233056 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL10961549 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL8741844 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL17315852 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL3016254 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL284705 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL337998 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL337341 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL6817517 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL648617 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 545 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3645499-B1 | PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS | VITAWORKS IP LLC (US) | 2024-03-13 | — | — | EP | claimed |
| US-20220143150-A1 | GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONIST ANALOG, PROCESS OF PREPARATION AND USES THEREOF | ENZENE BIOSCIENCES LIMITED (IN) | 2022-05-12 | — | — | US | claimed |
| EP-3941936-A2 | PROCESS OF PREPARATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND THEIR ANALOGS | Enzene Biosciences Ltd. (IN) | 2022-01-26 | — | — | EP | claimed |
| EP-3921337-A2 | GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONIST ANALOG, PROCESS OF PREPARATION AND USES THEREOF | Enzene Biosciences Ltd. (IN) | 2021-12-15 | — | — | EP | claimed |
| CN-113748125-A | Glucagon-like peptide-1 (GLP-1) receptor agonists and analogs thereof | 恩泽生物科学有限公司 | 2021-12-03 | — | — | CN | claimed |
| CN-113631568-A | Glucagon-like peptide-1 (GLP-1) agonist analogs, methods of preparation and uses thereof | 恩泽生物科学有限公司 | 2021-11-09 | — | — | CN | claimed |
| WO-2020161664-A9 | GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONIST ANALOG, PROCESS OF PREPARATION AND USES THEREOF | ENZENE BIOSCIENCES LIMITED (IN) | 2021-09-23 | — | — | WO | claimed |
| WO-2020161664-A2 | GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONIST ANALOG, PROCESS OF PREPARATION AND USES THEREOF | ENZENE BIOSCIENCES LIMITED (IN) | 2020-08-13 | — | — | WO | claimed |
| EP-3645499-A1 | PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS | Vitaworks IP, LLC (US) | 2020-05-06 | — | — | EP | claimed |
| US-10239822-B2 | Process for the separation of long chain amino acids and dibasic acids | VITAWORKS IP, LLC (US) | 2019-03-26 | — | — | US | claimed |
| WO-2019005633-A1 | PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS | VITAWORKS IP, LLC (US) | 2019-01-03 | — | — | WO | claimed |
| US-20190002397-A1 | PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS | NATURAMIDE IP LLC | 2019-01-03 | — | — | US | claimed |
| US-5756594-A | CATALYTIC POLYMERIZATION OF ALDEHYDE CARBOXYLATE MONOMER TO FORM POLYACETAL AND CROSSLINKING WITH POLYVINYL ETHERS, DIESTERS, DIEPOXIDES, ANHYDRIDES, DINITRILES AND DIACYL COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1998-05-26 | — | — | US | claimed |
| US-5506332-A | COPOLYMERIZING GLYOXYLIC ESTERS WITH CYCLIC FORMALS USING ANIONIC OR CATIONIC CATALYSTS | BASF AKTIENGESELLSCHAFT (DE) | 1996-04-09 | — | — | US | claimed |
| US-12600759-B2 | Process of preparation of glucagon-like peptide-1 (GLP-1) receptor agonists and their analogs | ENZENE BIOSCIENCES LIMITED (IN) | 2026-04-14 | — | — | US | disclosed |
| US-20260092922-A1 | MARKERS FOR THE DIAGNOSIS OF BIOCHEMICAL RECURRENCE IN PROSTATE CANCER | BPGBIO INC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4706633-A1 | COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-5019297-A | Catalysis with hydrogenated palladium | HENKEL RESEARCH CORPORATION (US) | 1991-05-28 | — | — | US | disclosed |
| WO-1990012859-A1 | A PROCESS FOR ISOMERIZING OLEFINICALLY UNSATURATED SECONDARY ALCOHOLS | HENKEL RESEARCH CORPORATION (US) | 1990-11-01 | — | — | WO | disclosed |
| US-4124608-A | Preparation of 2-oxoalkanoic acids | TEXACO INC. (US) | 1978-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092922-A1 | MARKERS FOR THE DIAGNOSIS OF BIOCHEMICAL RECURRENCE IN PROSTATE CANCER | ACP3, KLK3, APOB | CES2 1654/4885CES1 620/4885HAO1 3013/4885 |
| US-12600759-B2 | Process of preparation of glucagon-like peptide-1 (GLP-1) receptor agonists and their analogs | GLP1R, GIPR, GCG | CES2 4596/4885CES1 2531/4885HAO1 2544/4885 |
| US-20190002397-A1 | PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS | HACD2, HACD3, BCAT1 | CES2 3082/4885CES1 1435/4885HAO1 77/4885 |
| US-10239822-B2 | Process for the separation of long chain amino acids and dibasic acids | HACD2, HACD3, BCAT1 | CES2 3082/4885CES1 1435/4885HAO1 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.